Canaccord Genuity Maintains Buy on Stride, Lowers Price Target to $125
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Jason Tilchen maintains Stride (NYSE:LRN) with a Buy and lowers the price target from $175 to $125.
Canaccord Genuity analyst Jason Tilchen maintains Stride (NYSE:LRN) with a Buy and lowers the price target from $175 to $125.